New England Securities’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
$264K Buy
1,654
+743
+82% +$116K 0.09% 219
2014
Q3
$128K Sell
911
-306
-25% -$40K 0.04% 370
2014
Q2
$144K Sell
1,217
-670
-36% -$77.6K 0.05% 364
2014
Q1
$233K Sell
1,887
-428
-18% -$51.9K 0.09% 228
2013
Q4
$264K Buy
2,315
+1
+0% +$114 0.11% 217
2013
Q3
$259K Buy
2,314
+1
+0% +$108 0.13% 188
2013
Q2
$228K Buy
+2,313
New +$240K 0.15% 157

Other funds holding AMGN

New England Securities's AMGN Position: Q4 2014 in Review

New England Securities increased its Amgen (AMGN) stake by 82% in Q4 2014, buying an estimated $116K and bringing the position to 1,654 shares worth $264K. The position accounts for 0.09% of the portfolio, ranked #219.

New England Securities first reported a position in AMGN in Q2 2013 and has held it in 7 quarters since. 1,340 funds tracked by Wall St. Rank hold AMGN as of Q4 2014.

  • New England Securities held 1,654 shares of Amgen worth $264K as of Q4 2014.
  • New England Securities bought 743 Amgen shares in Q4 2014, an estimated $116K.
  • Amgen made up 0.09% of New England Securities's portfolio in Q4 2014, its #219 holding.
  • New England Securities first reported a position in Amgen in Q2 2013 and has held it in 7 quarters since.
  • 1,340 funds tracked by Wall St. Rank held Amgen as of Q4 2014.

Based on New England Securities's 13F filing for Q4 2014, filed 26 Jan 2015.